Plasma PCSK9 preferentially reduces liver LDL receptors in mice

This publication has 32 references indexed in Scilit:

• Molecular basis for LDL receptor recognition by PCSK9
  Proceedings of the National Academy of Sciences, 2008
• Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity
  Biochemical Journal, 2007
• The Cellular Trafficking of the Secretory Proprotein Convertase PCSK9 and Its Dependence on the LDLR
  Traffic, 2007
• Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart Disease
  New England Journal of Medicine, 2006
• Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9
  Proceedings of the National Academy of Sciences, 2005
• Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype
  Proceedings of the National Academy of Sciences, 2004
• Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes
  Proceedings of the National Academy of Sciences, 2003
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation
  Proceedings of the National Academy of Sciences, 2003
• Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
  Journal of Clinical Investigation, 1993